Literature DB >> 2779364

Age-related changes in the lipid compositions of rat and human tissues.

A Kalén1, E L Appelkvist, G Dallner.   

Abstract

The levels of cholesterol, ubiquinone, dolichol, dolichyl-P, and total phospholipids in human lung, heart, spleen, liver, kidney, pancreas, and adrenal from individuals from one-day-old to 81 years of age were investigated and compared with the corresponding organs from 2 to 300 day-old rats. The amount of cholesterol in human tissues did not change significantly during aging, but the level of this lipid in the rat was moderately elevated in the organs of the oldest animals. In human pancreas and adrenal the ubiquinone content was highest at one year of age, whereas in other organs the corresponding peak value was at 20 years of age, and was followed by a continuous decrease upon further aging. A similar pattern was observed in the rats, with the highest concentration of ubiquinone being observed at 30 days of age. Dolichol levels in human tissues increase with aging, but they increase to very different extents. In the lungs this increase is seven-fold, and in the pancreas it is 150-fold. The elevation in the dolichol contents of rat tissues ranges from 20 to 30-fold in our material. In contrast, the levels of the phosphorylated derivative of dolichol increased to a more limited extent, i.e., 2 to 6-fold in human tissues and even less in the rat. These results demonstrate that the levels of a number of lipids in human and rat organs are modified in a characteristic manner during the life-span. This is in contrast to phospholipids, which constitute the bulk of the cellular lipid mass.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2779364     DOI: 10.1007/BF02535072

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  27 in total

Review 1.  The biological role of dolichol.

Authors:  T Chojnacki; G Dallner
Journal:  Biochem J       Date:  1988-04-01       Impact factor: 3.857

2.  The alpha-saturation and terminal events in dolichol biosynthesis.

Authors:  T J Ekström; T Chojnacki; G Dallner
Journal:  J Biol Chem       Date:  1987-03-25       Impact factor: 5.157

3.  Distribution of dolichol and dolichyl phosphate in human brain.

Authors:  M Andersson; E L Appelkvist; K Kristensson; G Dallner
Journal:  J Neurochem       Date:  1987-09       Impact factor: 5.372

4.  2H NMR investigation of the organization and dynamics of polyisoprenols in membranes.

Authors:  J S de Ropp; F A Troy
Journal:  J Biol Chem       Date:  1985-12-15       Impact factor: 5.157

5.  Presence of dolichol and its derivatives in human blood.

Authors:  P G Elmberger; P Engfeldt; G Dallner
Journal:  J Lipid Res       Date:  1988-12       Impact factor: 5.922

6.  Age-associated increase of free dolichol levels in mice.

Authors:  R K Pullarkat; H Reha; P S Pullarkat
Journal:  Biochim Biophys Acta       Date:  1984-05-11

7.  Brain dolichyl pyrophosphate phosphatase. Solubilization, characterization, and differentiation from dolichyl monophosphate phosphatase activity.

Authors:  M G Scher; C J Waechter
Journal:  J Biol Chem       Date:  1984-12-10       Impact factor: 5.157

8.  Accumulation of dolichols in brains of elderly.

Authors:  R K Pullarkat; H Reha
Journal:  J Biol Chem       Date:  1982-06-10       Impact factor: 5.157

9.  Quantitation of dolichyl phosphate and dolichol in major organs of the rat as a function of age.

Authors:  R K Keller; S W Nellis
Journal:  Lipids       Date:  1986-05       Impact factor: 1.880

10.  Compartmentalization of phosphatidylethanolamine in microsomal membranes from rat liver.

Authors:  C Valtersson; G Dallner
Journal:  J Lipid Res       Date:  1982-08       Impact factor: 5.922

View more
  82 in total

Review 1.  The Beneficial Effects of Antioxidants in Health And Diseases.

Authors:  Sabina Janciauskiene
Journal:  Chronic Obstr Pulm Dis       Date:  2020-07

2.  Role of Coenzyme Q10 in Prophylaxis of Myocardial Infarction.

Authors:  Iftikhar Ali Shah; Mubeen Memon; Sheeba Ansari; Ratan Kumar; Sultan A Chandio; Shahid H Mirani; Amber Rizwan
Journal:  Cureus       Date:  2021-02-04

3.  Coenzyme Q10 administration increases brain mitochondrial concentrations and exerts neuroprotective effects.

Authors:  R T Matthews; L Yang; S Browne; M Baik; M F Beal
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-21       Impact factor: 11.205

4.  Coenzyme Q10 protects against acute consequences of experimental myocardial infarction in rats.

Authors:  Samy M Eleawa; Mahmoud Alkhateeb; Sanjoy Ghosh; Fahaid Al-Hashem; Abdullah S Shatoor; Abdulmohsen Alhejaily; Mohammad A Khalil
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2015-03-20

5.  Effect of coenzyme Q10 in Europeans with chronic heart failure: A sub-group analysis of the Q-SYMBIO randomized double-blind trial.

Authors:  Anne Louise Mortensen; Franklin Rosenfeldt; Krzysztof J Filipiak
Journal:  Cardiol J       Date:  2019-03-05       Impact factor: 2.737

6.  4-Nitrobenzoate inhibits coenzyme Q biosynthesis in mammalian cell cultures.

Authors:  Ulrika Forsman; Mats Sjöberg; Mikael Turunen; Pavel J Sindelar
Journal:  Nat Chem Biol       Date:  2010-06-06       Impact factor: 15.040

Review 7.  The effect of HMG-CoA reductase inhibitors on coenzyme Q10: possible biochemical/clinical implications.

Authors:  Iain P Hargreaves; Andrew J Duncan; Simon J R Heales; John M Land
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

8.  Distribution of ubiquinone and ubiquinol homologues in rat tissues and subcellular fractions.

Authors:  T Takahashi; T Okamoto; K Mori; H Sayo; T Kishi
Journal:  Lipids       Date:  1993-09       Impact factor: 1.880

Review 9.  Coenzyme Q, oxidative stress and aging.

Authors:  Rajindar S Sohal; Michael J Forster
Journal:  Mitochondrion       Date:  2007-03-30       Impact factor: 4.160

10.  Quantification of dolichol in the human lens with different types of cataracts.

Authors:  Devarshi Gajjar; Adam Jozwiak; Ewa Swiezewska; Bhagwat Alapure; Trilok Parmar; Kaid Johar; Abhay R Vasavada
Journal:  Mol Vis       Date:  2009-08-11       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.